Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Armata Pharmaceuticals Inc (ARMP)

Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 70,557
  • Shares Outstanding, K 36,183
  • Annual Sales, $ 4,530 K
  • Annual Income, $ -69,050 K
  • EBIT $ -41 M
  • EBITDA $ -41 M
  • 60-Month Beta 0.78
  • Price/Sales 15.82
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.35
  • Number of Estimates 1
  • High Estimate -0.35
  • Low Estimate -0.35
  • Prior Year -0.55
  • Growth Rate Est. (year over year) +36.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8900 +3.17%
on 12/19/24
2.4011 -18.79%
on 11/27/24
-0.1400 (-6.70%)
since 11/20/24
3-Month
1.8900 +3.17%
on 12/19/24
2.9600 -34.12%
on 11/13/24
-0.4500 (-18.75%)
since 09/20/24
52-Week
1.8900 +3.17%
on 12/19/24
4.4800 -56.47%
on 03/04/24
-0.4900 (-20.08%)
since 12/20/23

Most Recent Stories

More News
Armata Pharmaceuticals Announces Presentation at Phage Futures: Global Digital Summit 2023

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical stage biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.52%)
Armata Pharmaceuticals to Participate in the Cantor Global Healthcare Conference

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics...

ARMP : 1.9500 (-1.52%)
Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.52%)
Armata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Update

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.52%)
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2022 Results and Provides Corporate Update

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.52%)
Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities LLC

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.52%)
INVA : 17.84 (-0.50%)
Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.52%)
Armata Pharmaceuticals Announces Third Quarter 2022 Results and Provides Corporate Update

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.52%)
Armata Pharmaceuticals Announces Second Quarter 2022 Results and Provides Corporate Update

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

ARMP : 1.9500 (-1.52%)
Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata," "us," "our," or the "Company"), a biotechnology company focused on...

ARMP : 1.9500 (-1.52%)

Business Summary

Armata Pharmaceuticals Inc. is a biotechnology company. It is focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. The company's principal product candidate consist AP-SA01, targets Staphylococcus aureus including...

See More

Key Turning Points

3rd Resistance Point 2.1000
2nd Resistance Point 2.0500
1st Resistance Point 2.0000
Last Price 1.9500
1st Support Level 1.9000
2nd Support Level 1.8500
3rd Support Level 1.8000

See More

52-Week High 4.4800
Fibonacci 61.8% 3.4906
Fibonacci 50% 3.1850
Fibonacci 38.2% 2.8794
Last Price 1.9500
52-Week Low 1.8900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar